| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Alkermes Plc (ALKS) has 14 insiders with recent SEC Form 4 filings, including 0 buys and 13 sells. ALKS is classified in the Pharmaceuticals industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| VP | 225.5K | $10.95M | -2,034 | |
| VP | 109.2K | $5.30M | - | |
| VP | 69.4K | $3.37M | -9,000 | |
| Dir | 43.3K | $2.11M | -44,472 | |
| CFO | 36.7K | $1.78M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jul 16, 2018 | Bloom Floyd E | Director | Sell | 20,000 | $43.95 | $879,024.00 | -13.5% | |
| Jul 3, 2018 | Mitchell Paul J | Director | Sale+OE | 1,000 | $41.86 | $41,860.00 | -100% | |
| Jun 12, 2018 | Frates James M83 | SVP, Alks Inc; CFO Alks | Sell | 16,842 | $50.00 | $842,179.16 | -31.1% | |
| Jun 1, 2018 | Mitchell Paul J | Director | Sale+OE | 1,000 | $47.34 | $47,340.00 | -100% | |
| May 24, 2018 | Landine Michael J | SVP, Corp Dev., Alkermes, Inc. | Sale+OE | 20,000 | $45.22 | $904,424.00 | -10.4% | |
| May 22, 2018 | Pops Richard F57 | Director And CEO, Alkermes Plc | Sale+OE | 20,000 | $45.46 | $909,163.44 | -1.5% | |
| May 17, 2018 | Landine Michael J | SVP, Corp Dev., Alkermes, Inc. | Sale+OE | 20,000 | $46.14 | $922,846.04 | -5.4% | |
| May 15, 2018 | Pops Richard F57 | Director And CEO, Alkermes Plc | Sale+OE | 50,000 | $46.38 | $2,319,100.00 | -7.0% | |
| May 8, 2018 | Pops Richard F57 | Director And CEO, Alkermes Plc | Sale+OE | 50,000 | $44.32 | $2,215,774.56 | -3.6% | |
| May 1, 2018 | Mitchell Paul J | Director | Sale+OE | 1,000 | $44.32 | $44,320.00 | -100% |